JianguoTaoMD

Pathology • Charlottesville, VA

Hematopathology, Anatomic Pathology, Clinical Pathology

Assistant Professor, Oncologic Sciences, USF-Morsani

Join to view full profile

Dr. Tao is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Tao's full profile

Already have an account?

Office
1215 Lee St
Charlottesville, VA 22908
Phone+1 888-882-3990

Fax+1 434-243-6499

Education & Training

Zucker School of Medicine at Hofstra/NorthwellResidency, Pathology-Anatomic and Clinical, 1996 - 2000
Henan Medicine UniversityClass of 1985

Certifications & Licensure

VA State Medical License 2021 - 2026
FL State Medical License 2002 - 2024
GA State Medical License 2021 - 2023
NY State Medical License 2021 - 2023
PA State Medical License 2000 - 2001
American Board of Pathology Anatomic Pathology & Clinical Pathology
American Board of Pathology Hematology

Publications & Presentations

PubMed

Concurrent involvement of the bone marrow by BRAF V600E-mutant melanoma and hairy cell leukemia.
Margaret Moore, Pranav Patel, Jianguo Tao
Journal of Hematopathology. 2024-12-01
5 citations
Exploiting the fibroblast growth factor receptor-1 vulnerability to therapeutically restrict the MYC-EZH2-CDKN1C axis-driven proliferation in Mantle cell lymphoma.
Anuvrat Sircar, Satishkumar Singh, Zijun Y Xu-Monette, Krysta Mila Coyle, Laura K Hilton
Leukemia. 2023-10-01
MCL1 as a therapeutic vulnerability in Burkitt lymphoma.
Ren Yuan, Michelle Y Wang, Chengfeng Bi, Xiaohong Zhao, Jianguo Tao
Leukemia. 2023-04-01

Lectures

Targeting Oncoprotein Translation with Rocaglates in MYC-Driven Lymphoma
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

Iron Chelation and 2‐Oxoglutarate‐Dependent Dioxygenase Inhibition Suppress Mantle Cell Lymphoma's Cyclin D1September 13th, 2019
Uncovering, Reversing Venetoclax Resistance in LymphomaJuly 17th, 2019
Why Lymphoma Patients May Become Resistant to Specific TherapyMay 16th, 2019
Join now to see all